| RSS
Business center
Office
Post trade leads
Post
Rank promotion
Ranking
 
You are at: Home » News » International »

FDA approves Allergan-Gedeon’s Vraylar to treat bipolar depression

Increase font size  Decrease font size Date:2019-06-03   Views:433

Allergan and Gedeon Richter have secured US Food and Drug Administration (FDA) approval for the use of Vraylar (cariprazine) to treat bipolar I disorder.

 
 
[ Search ]  [ ]  [ Email ]  [ Print ]  [ Close ]  [ Top ]

 
Total:0comment(s) [View All]  Related comment

 
Recomment
Popular
 
 
Home | About | Service | copyright | agreement | contact | about | SiteMap | Links | GuestBook | Ads service | 京ICP 68975478-1
Tel:+86-10-68645975           Fax:+86-10-68645973
E-mail:yaoshang68@163.com     QQ:1483838028